97 related articles for article (PubMed ID: 22172853)
1. Liver graft failure and hyperbilirubinemia in liver transplantation recipients after Clostridium difficile infection.
Rochon C; Kardashian A; Mahadevappa B; Gunasekaran G; Sharma J; Sheiner P
Transplant Proc; 2011 Dec; 43(10):3819-23. PubMed ID: 22172853
[TBL] [Abstract][Full Text] [Related]
2. The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
Sullivan T; Weinberg A; Rana M; Patel G; Huprikar S
Transplantation; 2016 Sep; 100(9):1939-43. PubMed ID: 27379554
[TBL] [Abstract][Full Text] [Related]
3. Impact of center volume on outcomes of increased-risk liver transplants.
Ozhathil DK; Li YF; Smith JK; Tseng JF; Saidi RF; Bozorgzadeh A; Shah SA
Liver Transpl; 2011 Oct; 17(10):1191-9. PubMed ID: 21604357
[TBL] [Abstract][Full Text] [Related]
4. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection increases mortality risk in lung transplant recipients.
Lee JT; Kelly RF; Hertz MI; Dunitz JM; Shumway SJ
J Heart Lung Transplant; 2013 Oct; 32(10):1020-6. PubMed ID: 23891145
[TBL] [Abstract][Full Text] [Related]
6. Impact of reversible cardiac arrest in the brain-dead organ donor on the outcome of adult liver transplantation.
Levesque E; Hoti E; Khalfallah M; Salloum C; Ricca L; Vibert E; Azoulay D
Liver Transpl; 2011 Oct; 17(10):1159-66. PubMed ID: 21744468
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile infection and liver disease.
Musa S; Moran C; Rahman T
J Gastrointestin Liver Dis; 2010 Sep; 19(3):303-10. PubMed ID: 20922196
[TBL] [Abstract][Full Text] [Related]
8. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
[TBL] [Abstract][Full Text] [Related]
9. Orthotopic liver transplant using allografts from geriatric population in the United States: is there any age limit?
Singhal A; Sezginsoy B; Ghuloom AE; Hutchinson IV; Cho YW; Jabbour N
Exp Clin Transplant; 2010 Sep; 8(3):196-201. PubMed ID: 20716036
[TBL] [Abstract][Full Text] [Related]
10. Donor age as a predictor of risk for short-term outcomes after liver transplant.
Macedo FI; Miranda LE; Fernandes JL; Pádua TC; Figueroa JN; Neto OL; Lacerda CM
Exp Clin Transplant; 2010 Sep; 8(3):202-9. PubMed ID: 20716037
[TBL] [Abstract][Full Text] [Related]
11. Donor and recipient selection leads to good patient and graft outcomes for right lobe split transplantation versus whole graft liver transplantation in adult recipients.
Sandroussi C; Crawford M; Lockwood DS; Tang P; Gallagher JP; Pleass H; Strasser SI; Shackel NA; McCaughan GW; Verran DJ
Liver Transpl; 2009 Nov; 15(11):1586-93. PubMed ID: 19877214
[TBL] [Abstract][Full Text] [Related]
12. Response failure to the treatment of Clostridium difficile infection and its impact on 30-day mortality.
Kim ES; Kim YJ; Park CW; Cho KB; Jang BK; Chung WJ; Hwang JS; Park KS
Hepatogastroenterology; 2013 May; 60(123):543-8. PubMed ID: 23108084
[TBL] [Abstract][Full Text] [Related]
13. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
[TBL] [Abstract][Full Text] [Related]
14. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection.
Mattila E; Uusitalo-Seppälä R; Wuorela M; Lehtola L; Nurmi H; Ristikankare M; Moilanen V; Salminen K; Seppälä M; Mattila PS; Anttila VJ; Arkkila P
Gastroenterology; 2012 Mar; 142(3):490-6. PubMed ID: 22155369
[TBL] [Abstract][Full Text] [Related]
15. Results with expanded donor acceptance criteria in heart transplantation.
Forni A; Luciani GB; Chiominto B; Pizzuti M; Mazzucco A; Faggian G
Transplant Proc; 2011 May; 43(4):953-9. PubMed ID: 21620025
[TBL] [Abstract][Full Text] [Related]
16. Risk factors in liver retransplantation: a single-center experience.
Crivellin C; De Martin E; Germani G; Gambato M; Senzolo M; Russo FP; Vitale A; Zanus G; Cillo U; Burra P
Transplant Proc; 2011 May; 43(4):1110-3. PubMed ID: 21620065
[TBL] [Abstract][Full Text] [Related]
17. Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding.
Bispo M; Marcelino P; Marques HP; Martins A; Perdigoto R; Aguiar MJ; Mourão L; Barroso E
Liver Transpl; 2011 Mar; 17(3):270-8. PubMed ID: 21384509
[TBL] [Abstract][Full Text] [Related]
18. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
[TBL] [Abstract][Full Text] [Related]
19. Elderly donors for HCV(+) versus non-HCV recipients: patient survival following liver transplantation.
Boin IF; Ataide EC; Leonardi MI; Stucchi R; Sevá-Pereira T; Pereira IW; Cardoso AR; Caruy CA; Luzo A; Leonardi LS
Transplant Proc; 2008 Apr; 40(3):792-6. PubMed ID: 18455019
[TBL] [Abstract][Full Text] [Related]
20. Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region.
Blok JJ; Braat AE; Adam R; Burroughs AK; Putter H; Kooreman NG; Rahmel AO; Porte RJ; Rogiers X; Ringers J; ;
Liver Transpl; 2012 Jan; 18(1):112-9. PubMed ID: 21987454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
